InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+3.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by HULL CARL, Director. Director active across 2 companies, notably Ortho Clinical Diagnostics Holdings plc. Aggregated, 11 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €921k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 11 November 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
175,000 shares@ US$5.6474.4% of flowClass A Common StockSEC:0001823239-24-000113:0
Ideal exit: 8 Aug 2025 (T+270)
17,560 shares@ US$7.7010.0% of flowClass A Common StockSEC:0001823239-24-000034:0
10,729 shares@ US$5.484.4% of flowClass A Common StockSEC:0001823239-24-000023:0
75,842 sharesClass A Common StockSEC:0001823239-24-000008:0
147,638 sharesClass A Common StockSEC:0001823239-23-000026:0
9,719 shares@ US$15.2311.1% of flowClass A Common StockSEC:0001823239-23-000008:0
21,011 sharesOrdinary Shares, $0.00001 par valueSEC:0001209191-22-033124:0
81,600 sharesClass A Common StockSEC:0000899243-22-003415
81,600 sharesClass A Common StockSEC:0000899243-22-003415:0
2,600 sharesOrdinary SharesSEC:0001209191-21-030376
2,600 shares0Ordinary SharesSEC:0001209191-21-030376:0
11 of 11 declarations
About HULL CARL
Carl Hull is the CEO and Director at Ortho Clinical Diagnostics Holdings plc and Maravai Lifesciences Holdings, Inc. In these roles, he is responsible for the strategic and operational direction of these companies. His leadership is crucial for their success.
